Shares of Cambridge Cognition Holdings Plc (LON:COG – Get Free Report) passed below its fifty day moving average during trading on Monday . The stock has a fifty day moving average of GBX 29.60 and traded as low as GBX 28.45. Cambridge Cognition shares last traded at GBX 31.90, with a volume of 85,994 shares.
Analyst Ratings Changes
Separately, Panmure Gordon reaffirmed a “buy” rating and set a GBX 56 price target on shares of Cambridge Cognition in a report on Monday, January 19th. One analyst has rated the stock with a Buy rating, Based on data from MarketBeat, the company presently has a consensus rating of “Buy” and a consensus price target of GBX 56.
Check Out Our Latest Analysis on COG
Cambridge Cognition Stock Performance
Cambridge Cognition Company Profile
Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB digital cognitive assessment platform for drug development by enabling pharmaceutical companies to take new therapeutics from preclinical consultancy to pivotal studies and approval, as well as supports sponsors to enhance recruitment, develop safe and effective treatments, and enhance research and development efficiency.
Read More
- Five stocks we like better than Cambridge Cognition
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- NEW LAW: Congress Approves Setup For Digital Dollar?
- If You Keep Cash In A U.S. Bank Account… Read This NOW
- Executive Order 14330: Trump’s Biggest Yet
Receive News & Ratings for Cambridge Cognition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cambridge Cognition and related companies with MarketBeat.com's FREE daily email newsletter.
